https://www.selleckchem.com/products/mek162.html
6-62.6] vs. 45.4 [95% CI 41.0-50.0], p0.001). When comparing physicians and APPs, APPs were paid significantly less ($146.5 [95% CI $145.6-$147.5] vs. $119.7 [95% CI $117.6-$121.8], p0.001). As a percent of the number of total beneficiaries in each state, the percent of Medicare patients receiving ≥1 CM chemodenervation treatment from a high-volume provider in 2017 ranged from 0.024% (24 patients of 98,033 beneficiaries) in Wyoming to 0.135% (997 of 736,521) in Arizona, with six states falling outside of this range. Chemodenervat
Curtir
Comentario
Compartilhar
